OX40 is a secondary co-stimulatory immune checkpoint molecule predominantly expressed on activated T CD4+ cells and inhibition of the OX40/OX40 ligand signal pathway has successfully been used for the treatment of autoimmune diseases. Here, TNFRSF4 is linked to autoimmune disease.